M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1
L Zhang, S Gu, L Wang, L Zhao, X Zhao, L Zhang - 2024 - researchsquare.com
M2-like tumor-associated macrophages (M2-like TAMs) are known to play a significant role
in the progression of triple-negative breast cancer (TNBC) by creating an …
in the progression of triple-negative breast cancer (TNBC) by creating an …
ERS International Congress 2021: highlights from the Thoracic Surgery and Lung Transplantation Assembly
S Bos, S Ricciardi, EJ Caruana, NAA Öztürk… - ERJ Open …, 2022 - Eur Respiratory Soc
The thoracic surgery and lung transplantation assembly of the European Respiratory Society
(ERS) is delighted to present the highlights from the 2021 ERS International Congress. We …
(ERS) is delighted to present the highlights from the 2021 ERS International Congress. We …
Research progress on immunotherapy for triple-negative breast cancer
L HE, X ZHU, Y JIANG - Chinese Journal of Clinical …, 2023 - manu41.magtech.com.cn
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the
absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …
absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …
Polymeric micelles as delivery systems for anticancer immunotherapy
NN Parayath - Polymeric Micelles for Drug Delivery, 2022 - Elsevier
The use of immunotherapeutic agents has been in the forefront of investigative cancer
therapy approaches over the past decade. The concept of using body's own defense …
therapy approaches over the past decade. The concept of using body's own defense …
[引用][C] Baş-boyun skuamöz hücre karsinoması ve makrofaj hücrelerinin apelin/APJ ekseninde moleküler bağlantılarının araştırılması
F Seçer Çelik - 2022 - Necmettin Erbakan Üniversitesi …
Analysis of Tumor Immune Microenvironment Based on Bulk RNA-sequencing Data and Its Application
C Xiao, REN Huan - Cancer Research on Prevention and Treatment, 2023 - zlfzyj.com
Cancer immunotherapy is one of the most promising biological therapies. The dynamic
changes of the immune microenvironment of heterogeneous tumors are critical factors in …
changes of the immune microenvironment of heterogeneous tumors are critical factors in …
An insight into the development of triple-negative breast cancer at transcriptome level based on single-cell sequencing technology
B Jin, Z Zhu, J Ma - 2022 - researchsquare.com
Poor prognosis and low survival rate always hinder the research on the mechanism and
pathology of triple-negative breast cancer (TNBC). With the rapid development of …
pathology of triple-negative breast cancer (TNBC). With the rapid development of …
Application progress of single-cell sequencing technology in breast cancer research
LIU Qiang, F Yi, W Jing - China Oncology, 2022 - china-oncology.com
Breast cancer is a malignant tumor with the highest incidence in women in the world, and it
represents the leading cause of cancer-related deaths in women. Breast cancer is a highly …
represents the leading cause of cancer-related deaths in women. Breast cancer is a highly …
Malignant cell related gene signature for patients with triple-negative breast cancer based on integrated analysis of single cell and bulk RNA sequencing
L Yi, K Zhao - 2023 - researchsquare.com
Background: Triple-negative breast cancer (TNBC) is the heterogeneous cancer. TNBC
tissues comprise of malignant epithelial cells and non-malignant epithelial cells. Our study …
tissues comprise of malignant epithelial cells and non-malignant epithelial cells. Our study …
[PDF][PDF] Maestría y Doctorado en Ciencias Bioquímicas
DDEFT DE MACRÓFAGOS - 2022 - ru.dgb.unam.mx
El cáncer es un conjunto de enfermedades que se caracteriza por una proliferación
desregulada de células anormales que pueden esparcirse a otros tejidos del cuerpo y …
desregulada de células anormales que pueden esparcirse a otros tejidos del cuerpo y …